Navigating Coverage Decisions for Cell & Gene Therapies: A Payer Perspective

• Balancing clinical evidence standards, financial risk and member access
• Supporting employer evaluation of high-cost therapies, including the use of carveouts, reinsurance, and care management strategies.
• Assessing differences between large and small employer groups and their sensitivity to single high-cost claims

Speakers:

Paul Eiting

Managing Director, Legislative and Regulatory Policy

Blue Cross & Blue Shield Association